[IP Daily Plus]는 개별 신청을 통해 소장원문, 계쟁특허,분쟁이력 등의 추가정보를 제공해드리는 서비스입니다.
의약품
Alexion Pharmaceuticals Inc
v.
OO Bioepis Co LTD
간의
특허 관련
특허 분쟁
사건번호 |
1:24-cv-00005
|
발생일자 |
2024.01.03
|
법원국가 |
UNITED STATES OF AMERICA
|
관할법원명 |
D.C.Delaware
|
침해권리 |
특허
|
산업분류 |
화학∙바이오
> 의약품
|
소송유형 |
침해금지
|
분쟁결과(1심) |
진행중
|
원고명 |
Alexion Pharmaceuticals Inc / Alexion Pharma International Operations Ltd (영국 / 외국기업 )
|
피고명 |
OO Bioepis Co LTD (한국 / 대기업 )
|
분쟁내용 |
[Alexion Pharmaceuticals Inc et al v. OO Bioepis Co LTD] 사건번호 1:24-cv-00005에 따르면 원고 Alexion Pharmaceuticals Inc / Alexion Pharma International Operations Ltd은(는) 피고 OO Bioepis Co LTD을(를) 상대로 특허 US9732149|US9718880|US9725504|US10590189|US10703809|US9447176을(를) 침해했다는 이유로 미국 델라웨어 지방법원에 소를 제기하였다.
|
계쟁특허 대표도면[US9732149]
계쟁제품 |
biosimilar to SOLIRISⓇ (eculizumab), called SB12
|
계쟁특허 정보 |
특허번호 |
특허명칭 |
국내패밀리 정보 |
국제특허분류(IPC) |
US9732149
|
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
|
KR101197799B1
,
KR20070004084A
KR20070009996A
,
KR20080110800A
KR20090076960A
,
KR20140057635A
|
A61K 39/00
,
A61K 9/00
C07K 16/18
,
A61K 31/7105
A61K 38/00
|
US9718880
|
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
|
KR101197799B1
,
KR20070004084A
KR20070009996A
,
KR20080110800A
KR20090076960A
,
KR20140057635A
|
A61K 39/00
,
A61K 9/00
C07K 16/18
,
C07K 19/00
A61K 31/7105
,
A61K 38/00
|
US9725504
|
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
|
KR101197799B1
,
KR20070004084A
KR20070009996A
,
KR20080110800A
KR20090076960A
,
KR20140057635A
|
A61K 39/00
,
A61K 9/00
C07K 16/18
,
C07K 19/00
A61K 31/7105
,
A61K 38/00
|
US10590189
|
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
|
KR101197799B1
,
KR20070004084A
KR20070009996A
,
KR20080110800A
KR20090076960A
,
KR20140057635A
|
A61K 9/00
,
A61K 39/00
C07K 16/18
,
A61K 31/7105
A61K 38/00
|
US10703809
|
Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement
|
KR101197799B1
,
KR20070004084A
KR20070009996A
,
KR20080110800A
KR20090076960A
,
KR20140057635A
|
C07K 16/18
,
A61K 31/7105
A61K 9/00
,
A61K 38/00
A61K 39/00
|
US9447176
|
Methods and compositions for treating complement-associated disorders
|
KR20110094029A
|
A61K 39/00
,
A61K 38/00
C07K 16/18
,
C07K 19/00
|
|
등록일자:2024-01-05